U.S. Other Utilities Stock News

NasdaqGS:CBSH
NasdaqGS:CBSHBanks

Commerce Bancshares (CBSH) Valuation Check After FineMark Integration Costs And Analyst Downgrades

Commerce Bancshares (CBSH) is under scrutiny after missing first quarter revenue expectations and reporting higher than expected integration costs tied to its FineMark Holdings acquisition, with insider selling and cautious analyst commentary adding further pressure. See our latest analysis for Commerce Bancshares. Over the past year, Commerce Bancshares’ share price has been under pressure, with short term momentum soft despite a 5.58% 1 month share price return and a 1 year total...
NYSE:BKV
NYSE:BKVOil and Gas

A Look At BKV (BKV) Valuation After Hedge Fund Entry And Anticipation Of 2026 Earnings

Recent moves in BKV (BKV) stock come as investors weigh two catalysts: the upcoming May 7, 2026 earnings release, which is expected to show lower earnings on higher revenue, and fresh interest from a prominent hedge fund. See our latest analysis for BKV. At a share price of $31.32, BKV has seen a 14.98% 1 month share price return and a 68.39% 1 year total shareholder return, suggesting momentum has picked up as investors focus on the upcoming earnings update and hedge fund interest. If you...
NYSE:GVA
NYSE:GVAConstruction

A Look At Granite Construction (GVA) Valuation As Raised 2026 Guidance Follows Strong Q1 Results

Granite Construction (GVA) is back in focus after Q1 2026 results showed stronger than expected revenue, a higher full year revenue outlook to US$5.2b to US$5.4b, and record backlog supported by acquisitions. See our latest analysis for Granite Construction. The stronger Q1 2026 update appears to have fed into the share price, with Granite Construction’s 7 day share price return of 13.01% and 30 day return of 13.98% adding to a 1 year total shareholder return of 72.64%. This suggests momentum...
NYSE:GPOR
NYSE:GPOROil and Gas

A Look At Gulfport Energy’s (GPOR) Valuation As Earnings, Buybacks And Leadership Changes Draw Focus

Anticipation around Gulfport Energy (GPOR) is building as investors look toward the upcoming March quarter earnings report, which is expected to feature higher year over year earnings and revenue, along with continued share repurchases and leadership changes. See our latest analysis for Gulfport Energy. At a share price of US$189.90, Gulfport Energy has seen a 1 day share price return of a 1.4% decline and a 30 day share price return of a 9.4% decline, while its 3 year total shareholder...
NYSE:CALY
NYSE:CALYLeisure

Is It Too Late To Reassess Callaway Golf (CALY) After Its Recent Share Price Surge

If you are wondering whether Callaway Golf at around US$15.16 is still reasonably priced after its recent run, the valuation story is the key place to focus. The stock has seen sharp moves, with a 29.4% return year to date and 121.3% over the last year, set against a 32.1% decline over three years and a 51.3% decline over five years. These swings have kept Callaway Golf on many watchlists, as investors weigh shorter term momentum of 9.7% over the last 30 days against a 1% decline over the...
NYSE:BRK.A
NYSE:BRK.ADiversified Financial

A Look At Berkshire Hathaway’s Valuation As Shares Trade Below An Estimated Fair Value

Recent performance and business snapshot Berkshire Hathaway (BRK.A) has drawn investor attention after recent trading, with the share price closing at US$710,300 and short term returns mixed across the past week and month. Over the past 3 months, Berkshire Hathaway has recorded a total return of about 1.7% decline and about 4.5% decline year to date, while the 1 year total return shows about 12.2% decline. Longer term figures are different, with 3 year and 5 year total returns of 44.4% and...
NasdaqGS:MTCH
NasdaqGS:MTCHInteractive Media and Services

Is Match Group (MTCH) Quietly Recasting Its Moat Around Ultra-Niche LGBTQ Dating Communities?

In late April 2026, Match Group announced a US$100,000,000 minority investment in Sniffies, a real-time map-based cruising app for queer men, with an option to fully acquire the platform while keeping it founder-led and operationally independent. This move, alongside ongoing efforts to court LGBTQ users after acquiring Her, indicates Match Group is broadening its portfolio toward more niche, community-focused dating and social experiences. We’ll now explore how Match Group’s US$100,000,000...
NYSE:EE
NYSE:EEOil and Gas

Excelerate Energy (EE) Valuation Check As Investors Weigh LNG Growth Story Against Premium P/E Multiple

Without a specific news headline driving Excelerate Energy (EE) today, investors are focusing on the stock’s recent returns, its value score of 3, and the company’s role in global liquefied natural gas infrastructure. See our latest analysis for Excelerate Energy. At a share price of $34.47, Excelerate Energy’s recent 30-day share price return of 7.15% contrasts with a 90-day share price return decline of 7.71%. The 1-year total shareholder return of 35.40% and 3-year total shareholder return...
NasdaqGS:MEDP
NasdaqGS:MEDPLife Sciences

Raised 2026 Guidance And Leadership Change Might Change The Case For Investing In Medpace (MEDP)

In April 2026, Medpace Holdings reported first-quarter 2026 results showing sales of US$706.6 million and net income of US$123.87 million, with both basic and diluted earnings per share rising year over year, and issued full-year 2026 guidance for revenue of US$2.76–2.86 billion and GAAP net income of US$487.0–511.0 million alongside President Jesse Geiger’s planned retirement. An interesting detail for investors is that Medpace’s full-year 2026 outlook assumes a 19–20% tax rate and US$27.5...
NYSE:FIHL
NYSE:FIHLInsurance

Fidelis Buyback And Bye Law Changes Reframe Capital Return Outlook

Fidelis Insurance Holdings (NYSE:FIHL) has entered into a major share repurchase agreement that ends founding shareholder CVC Falcon Holdings Limited's ownership stake. The company has also approved amendments to its Bye Laws at its latest annual meeting, signaling changes to its governance framework. These decisions mark a meaningful shift in ownership and corporate rules that is relevant for existing and prospective shareholders. Fidelis Insurance Holdings, a specialty insurance and...
NasdaqGS:INCY
NasdaqGS:INCYBiotechs

Is It Too Late To Consider Incyte (INCY) After A 55% One Year Rally?

If you are wondering whether Incyte's current share price still offers value or has already priced in recent enthusiasm, the next sections will walk through what the numbers actually say. Over the past year the stock has returned 55.0%, with shorter term moves of 2.4% over 7 days, 2.8% over 30 days and a year to date return of a 4.4% decline, which can change how the market views both its growth potential and its risks. Recent coverage has focused on Incyte's position in biotech and the...
NYSE:HUN
NYSE:HUNChemicals

Huntsman Q1 Loss Of US$0.30 Per Share Tests Bullish Margin Recovery Narratives

Huntsman (HUN) opened 2026 with Q1 revenue of US$1.4 billion and a basic EPS loss of US$0.30, while the trailing twelve months show revenue of US$5.7 billion and a basic EPS loss of US$1.87. Over recent quarters, revenue has ranged between US$1.4 billion and US$1.5 billion, with quarterly basic EPS losses stretching from roughly US$0.02 to US$0.92. Investors are therefore looking at a business that is still working through margin pressure rather than expanding profitability. See our full...
NasdaqGS:TER
NasdaqGS:TERSemiconductor

Is It Too Late To Consider Buying Teradyne (TER) After Its 356.9% One-Year Surge?

Wondering if Teradyne at US$345.42 is priced for perfection or still offers value? This article breaks down what the current market price might be implying. The stock has seen sharp moves, with a 17.4% decline over the last 7 days, an 11.6% gain over 30 days, and returns of 66.4% year to date and 356.9% over the past year. Recent coverage of Teradyne has focused on its role in semiconductors and automation, and how investor interest in these themes has lined up with the share price moves...
NYSE:TEVA
NYSE:TEVAPharmaceuticals

Why Teva (TEVA) Is Up 14.1% After Strong Q1 Profitability And Neuroscience Pivot News

In late April 2026, Teva Pharmaceutical Industries reported first‑quarter 2026 results showing higher sales of US$3,982 million and net income of US$369 million, alongside much smaller impairment charges than a year earlier. Beyond the headline numbers, growth in innovative products such as UZEDY and the planned acquisition of Emalex Biosciences signal a deeper shift toward higher‑margin neuroscience and specialty medicines. Now we will examine how Teva’s stronger first‑quarter profitability...
NasdaqCM:NUTX
NasdaqCM:NUTXHealthcare

A Look At Nutex Health (NUTX) Valuation After Q1 2026 Earnings Surge And Expansion Plans

Nutex Health (NUTX) is back on investors’ radar after Q1 2026 results showed net income more than doubling year over year, stronger EPS, and continued hospital expansion plans supported by its existing arbitration driven model. See our latest analysis for Nutex Health. That earnings surprise and expansion pipeline have coincided with a sharp rebound in the shares, with a 1 day share price return of 17.1%, 7 day share price return of 28.9% and 30 day share price return of 41.8%. The 1 year...
NasdaqGS:GOOGL
NasdaqGS:GOOGLInteractive Media and Services

Is Alphabet (GOOGL) Pricing Reflect Recent AI Momentum Or Getting Ahead Of Itself?

Wondering if Alphabet's share price actually lines up with its underlying value, or if enthusiasm has run ahead of the numbers. Alphabet recently closed at US$385.69, with reported returns of 12.0% over 7 days, 29.7% over 30 days, 22.4% year to date and 135.9% over 1 year. Recent headlines have focused on Alphabet's role in artificial intelligence and ongoing product updates across search, cloud services and advertising. These stories help explain why investors are paying close attention to...
NasdaqGS:MXL
NasdaqGS:MXLSemiconductor

MaxLinear’s Washington TIA Targets AI Data Center Growth And Risks

MaxLinear (NasdaqGS:MXL) introduced its Washington 200G per lane optical transimpedance amplifier for 1.6T AI data center interconnects. Samples of the new TIA are currently available to customers, with mass production targeted for the second half of 2026. The launch comes as the company reports upgraded sales targets and momentum in its optical business. For investors tracking AI infrastructure, this move places MaxLinear closer to the core of next generation data center build outs. The...
NYSE:BWA
NYSE:BWAAuto Components

Should New Asian eMotor Contracts and Dividend Payouts Require Action From BorgWarner (BWA) Investors?

BorgWarner Inc. recently announced it will pay a quarterly dividend of US$0.1700 per share on June 15, 2026, and disclosed new eMotor contracts with Asian automakers for electric and hybrid vehicle programs in South Korea and China. These awards expand BorgWarner’s electrification footprint in key Asian markets by supplying stator assemblies and advanced winding technologies for next-generation hybrid and battery electric platforms. Next, we’ll examine how these new Asian eMotor program...
NasdaqGS:OKTA
NasdaqGS:OKTAIT

Is It Time To Reassess Okta (OKTA) After A 33% One Year Share Price Slip

This article examines whether Okta, trading at around US$75.78, may be attractively priced or could instead represent a value trap, and explores what the current price might be implying about the business. The stock has had a mixed performance, with a 0.3% decline over the past 7 days, a 4.3% drop over the last 30 days, a 9.4% fall year to date, and a 32.9% decline over the past year, while the 3-year return stands at 2.7% and the 5-year return at a 68.1% loss. Recent headlines have...
NYSE:FDS
NYSE:FDSCapital Markets

Is FactSet Research Systems (FDS) Now Pricing In Too Much Pessimism After 1-Year Slump

Wondering whether FactSet Research Systems at around US$227.58 still reflects its true worth, or if the market has moved ahead of the fundamentals. The stock has risen 1.5% over the last 7 days and 1.2% over the last 30 days, although year to date it is down 20.1% and the 1 year return sits at a 46.9% loss. These moves come as investors reassess established financial data and analytics providers. FactSet Research Systems is often mentioned in discussions around long term demand for market...